Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

China flag China · Delayed Price · Currency is CNY
20.10
+0.02 (0.10%)
Jul 29, 2026, 3:04 PM CST
Market Cap6.91B -19.4%
Revenue (ttm)3.11B +15.3%
Net Income95.72M -5.8%
EPS0.28 -3.4%
Shares Out 343.93M
PE Ratio71.56
Forward PE22.09
Dividend0.05 (0.25%)
Ex-Dividend DateJun 2, 2026
Volume2,483,680
Open19.87
Previous Close20.08
Day's Range19.87 - 20.44
52-Week Range17.98 - 31.20
Beta0.38
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-allergic, anticancer, anti-fungal, anti-epileptic, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It also provides fine chemicals and CDMO services. The company was founded in 1993 and is headquartered in Taizhou, China. [Read more]

Sector Healthcare
Founded 1993
Employees 4,686
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300702
Full Company Profile

Financial Performance

In 2025, SHE:300702's revenue was 3.06 billion, an increase of 16.36% compared to the previous year's 2.63 billion. Earnings were 139.71 million, an increase of 149.78%.

Financial Statements